Case of prostate stromal tumour of uncertain malignant potential where positron emission tomography with 18F-fluorodeoxyglucose was useful for surgical planning.
Issei SuzukiToshiki KijimaAtsuko OwadaTakao KamaiPublished in: BMJ case reports (2020)
Stromal tumour of uncertain malignant potential of the prostate is a rare tumour with a variable clinical behaviour ranging from incidentally detected indolent tumours that never progress, to aggressive diseases almost identical to sarcomas that may invade surrounding organs or develop metastases. Surgical excision is generally recommended for local diseases; however, owing to its diverse clinical outcomes, optimal management may vary from surgery alone to wide excision combined with chemotherapy and/or radiotherapy. Therefore, preoperative evaluation of the malignant potential of the disease is essential to decide the treatment strategy. Herein, we report a case of stromal tumour of uncertain malignant potential successfully treated with minimally invasive robot-assisted radical prostatectomy alone under the diagnosis of the disease with low malignant potential based on the findings of positron emission tomography with 18F-fluorodeoxyglucose.
Keyphrases
- positron emission tomography
- computed tomography
- minimally invasive
- prostate cancer
- robot assisted
- radical prostatectomy
- pet ct
- pet imaging
- bone marrow
- human health
- early stage
- locally advanced
- risk assessment
- squamous cell carcinoma
- coronary artery disease
- benign prostatic hyperplasia
- climate change
- percutaneous coronary intervention
- high grade